High aryl acylamidase activity associated with cobra venom acetylcholinesterase: Biological significance

Biochimie

Volumn 91, Issue 11-12, 2009, Pages 1450-1456

  Rajesh, Ramanna V ^a,b   Layer, Paul G ^c   Boopathy, Rathanam ^b  

^a National Institute of Animal Science   (South Korea)

^b BHARATHIAR UNIVERSITY   (India)

^c DARMSTADT UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

Acetylcholinesterase; Cobra venom; Serotonin

Indexed keywords

ACETYLCHOLINESTERASE; ARYL ACYLAMIDASE; CHOLINERGIC RECEPTOR BLOCKING AGENT; MONOMER; SEROTONIN ANTAGONIST; SNAKE VENOM;

ALZHEIMER DISEASE; ARTICLE; BIOLOGICAL ACTIVITY; BRAIN; CONCENTRATION RESPONSE; CONTROLLED STUDY; EEL; ENZYME ACTIVITY; ENZYME INHIBITION; GOAT; IN VITRO STUDY; NONHUMAN; PATHOGENESIS; SENSITIVITY ANALYSIS;

ACETYLCHOLINE; ACETYLCHOLINESTERASE; AMIDOHYDROLASES; ANIMALS; COBRA VENOMS; SEROTONIN; SUBSTRATE SPECIFICITY;

CAPRA HIRCUS; ELECTROPHORUS ELECTRICUS; SERPENTES;

EID: 72649104036     PISSN: 03009084     EISSN: 61831638     Source Type: Journal    
DOI: 10.1016/j.biochi.2009.08.004     Document Type: Article

References (52)

1. Glynis J., and Samuel S.W. The adhesion function on acetylcholinesterase is located at peripheral anionic site. Biochem. Biophys. Res. Commun. 258 (1999) 758-762
2. Brimijoin S., and Koenigsberger C. Cholinesterases in neural development: new findings and toxicologic implications. Environ. Health Perspect. 107 1 (1999) 59-64
3. Srivatsan M., and Peretz B. Acetylcholinesterase promotes regeneration of neuritis in cultured adult neurons of Aplysia. Neuroscience 77 (1997) 921-931
4. Balasubramanian A.S., and Bhanumathy C.D. Noncholinergic functions of cholinesterases. FASEB J. 7 (1993) 1354-1358
5. Chatonnet A., and Lockridge O. Comparison of butyrylcholinesterase and acetylcholinesterase. Biochem. J. 260 (1989) 625-634
6. Layer P.G., and Willbold E. Novel functions of cholinesterases in development, physiology and disease. Prog. Histochem. Cytochem. 29 3 (1995) 1-94
7. Massoulie J., Pezzementi L., Bon S., Krejci E., and Vallette F.M. Molecular and cellular biology of cholinesterases. Prog. Neurobiol. 41 (1993) 31-91
8. Boopathy R., and Layer P.G. Aryl acylamidase activity on acetylcholinesterase is high during early chicken brain development. Protein J. 23 (2004) 325-333
9. Iyenger N.K., Schra H.B., Mukeiji B., and Chopra R.N. Proteins in snake venom. Curr. Sci. India 7 (1938) 51-53
10. Zeller E.A. Enzymes of snake venoms as tools in biochemical research. Mem. Inst. Butantan 33 (1966) 349-357
11. Kumar V., and Elliott W.B. The acetylcholinesterase of Bungarus fasciatus venom. Eur. J. Biochem. 34 (1973) 586-592
12. Lee S.R., Latta J.L., and Elliott W.B. Isoenzymes of elapid acetylcholinesterases. Comp. Biochem. Physiol. C 56 (1977) 193-197
13. Cousin X., Creminon C., Grassi J., Meflah K., Cornu G., Saliou B., Bon S., Massoulie J., and Bon C. Acetylcholinesterase from Bungarus venom: a monomeric species. FEBS Lett. 387 (1996) 196-200
14. Raba R., Aaviskaar A., Raba M., and Siigur J. Cobra venom acetylcholinesterase. Eur. J. Biochem. 96 (1979) 151-158
15. Raba R., and Aaviskaar A. Cobra venom acetylcholinesterase: nature of charge isoforms. Eur. J. Biochem. 127 (1982) 507-512
16. Weise C., Kreienkamp H.J., Raba R., Aaviskaar A., and Hucho F. The active site and partial sequence of cobra venom acetylcholinesterase. J. Prot. Chem. 9 (1990) 53-57
17. Kreienkamp H.J., Weise C., Raba R., Aaviksaar A., and Hucho F. Investigation of ligand-binding sites of the acetylcholine receptor using photoactivatable derivatives of Neurotoxin II from Naja naja oxiana. Biochemistry 88 (1991) 6117-6121
18. Fujimoto D. Serotonin-sensitive aryl acylamidase activity of acetylcholinesterases. FEBS Lett. 71 (1976) 121-123
19. Oommen A., and Balasubramanian A.S. The association of the serotonin-sensitive aryl acylamidase with acetylcholinesterase in the monkey brain. Eur. J. Biochem. 94 (1979) 135-143
20. Majumdar R., George S.T., and Balasubramanian A.S. Serotonin-sensitive aryl acylamidase activity of platelet acetylcholinesterase. Biochem. Pharmacol. 31 (1982) 2319-2325
21. Tsujita T., and Okuda H. Carboxylesterases in rat and human sera and their relationship to serum aryl acylamidases and cholinesterases. Eur. J. Biochem. 133 (1983) 215-220
22. Rao R.V., Gnanamuthu C., and Balasubramanian A.S. Human cerebrospinal fluid acetylcholinesterase and butyrylcholinesterase. Evidence for identity between the serum and cerebrospinal fluid butyrylcholinesterase. Clin. Chim. Acta 183 (1989) 135-146
23. Checler F., Grassi J., and Vincent J.P. Cholinesterases display genuine arylacylamidase activity but are totally devoid of intrinsic peptidase activities. J. Neurochem. 62 (1994) 756-763
24. Jayanthi L.D., Balasubramanian N., and Balasubramanian A.S. Cholinesterases exhibiting aryl acylamidase activity in human amniotic fluid. Clin. Chim. Acta 205 (1992) 157-166
25. Rajesh R.V., Balasubramanian A.S., and Boopathy R. Identification of serotonin sensitive aryl acylamidase activity with cobra venom acetylcholinesterase. Indian J. Biochem. Biophys. 40 (2003) 92-97
26. Rajesh R.V., Balasubramanian A.S., and Boopathy R. Evidence for presence of Zn+2-binding site in acetylcholinesterase. Biochimie 91 (2009) 526-532
27. Hoagland R.E., and Graf G. Nitroacetanilides as chromogenic substrates for assaying de-acetylating activity: the isolation and partial purification of aryl acylamidases from erepsin and tulip. Enzymologia 41 (1971) 313-319
28. Ellman G.L., Courtney K.D., Andres Jr. V., and Feather-Stone R.M. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 7 (1961) 88-95
29. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the folin phenol reagent. J. Biol. Chem. 193 (1951) 265-275
30. Mounter L.A. The specificity of cobra venom cholinesterase. Biochem. J. 50 (1951) 122-128
31. Kumar V., and Elliot W.B. Acetylcholinesterase from Bungarus fasciatus venom-I. Substrate specificity. Comp. Biochem. Physiol. C 51 (1975) 249-253
32. Augustinsson K.B. Comparison between the acetylcholinesterase of helix blood and cobra venom-I. The hydrolysis of acetylcholine and its inhibition by various compounds. Acta Chem. Scand. 5 (1951) 699-711
33. Augustinsson K.B. Comparison between the acetylcho1inesterase of helix blood and cobra venom-II. The hydrolysis of certain choline and noncholine esters. Acta Chem. Scand. 5 (1951) 112-123
34. Kato G., Tan E., and Yung J. Acetylcholinesterase:kinetic studies on the mechanism of atropine inhibition. J. Biol. Chem. 247 (1971) 3186-3189
35. Changeux J.P. Responses of acetylcholinesterase from Torpedo marmorata to salts and curarizing drugs. Mol. Pharmacol. 2 (1966) 369-392
36. Montenegro M.F., Moral-Naranjo M.T., Paez de la Cadena M., Campoy F.J., Munoz-Delgado E., and Vidal C.J. Human butyrylcholinesterase components differ in aryl acylamidase activity. Biol. Chem. 389 (2008) 425-432
37. Agbaji A.S., Gerassimidis K., and Hider R.C. A comparison of eel electroplax and snake venom acetylcholinesterase. Comp. Biochem. Physiol. C 17 (1984) 211-216
38. Zeller E.A. Snake venom action: are enzymes involved in it?. Cell. Mol. Life Sci. 33 (1977) 143-150
39. Zhang Y., Lee W.H., Xiong Y.L., Wang W.Y., and Zhu S.W. Characterization of OhS1, an arginine/lysine amidase from the venom of king cobra. Toxicon 32 (1994) 615-623
40. Frobert Y., Creminon C., Cousin X., Remy M.H., Chateld J.M., Bon S., Bon C., and Grassi J. Acetylcholinesterases from Elapidae snake venoms: biochemical, immunological and enzymatic characterization. Biochim. Biophys. Acta 1339 (1997) 253-267
41. Messing R.B., and Lytle L.D. Serotonin containing neurons: their possible role in pain and analgesia. Pain 4 (1977) 1-21
42. Linker C., Casanueva O.I., Soto C., and Garrido J. Acetylcholinesterase accelerates assembly of amyloid beta-peptides into Alzheimer's fibrils: possible role of the peripheral site of the enzyme. Neuron 16 (1996) 881-891
43. Navaratnam D.S., Priddle J.D., McDonald B., Esiri M.M., Robinson J.R., and Smith A.D. Anomalous molecular form of acetylcholinesterase in cerebrospinal fluid in histologically diagnosed Alzheimer's disease. Lancet 337 (1991) 447-449
44. Ogane N., Giacobiniand E., and Struble R. Differential inhibition of acetylcholinesterase molecular forms in normal and Alzheimer disease brain. Brain Res. 589 (1992) 307-312
45. Giacobini E. The second generation of cholinesterase inhibitors: pharmacological aspects. In: Becker R., and Giacobini E. (Eds). Cholinergic Basis for Alzheimer Therapy (1991), Birkhauser, Boston 247-262
46. Alvarez A., Alarcon R., Opazo C., Campos E.O., Munoz F.J., Calderon F.H., Dajas F., Gentry M.K., Doctor B.P., De Mello F.G., and Inestrosa N.C. Stable complexes involving acetylcholinesterase and amyloid-β peptide change the biochemical properties of the enzyme and increase the neurotoxicity of Alzheimer's fibrils. J. Neurosci. 18 (1998) 3113-3223
47. Wright C.I., Geula C., and Mesulam M.M. Protease inhibitors and indoleamines selectively inhibit cholineaterases in the histopathologic structures of Alzheimer disease. Proc. Natl. Acad. Sci. 90 (1993) 683-686
48. Atack J.R., Perry E.K., Bonnam J.R., Candy J.M., and Perry R.H. Molecular forms of acetylcholinesterase and butyrylcholinesterase in the aged human central nervous system. J. Neurochem. 47 (1986) 263-277
49. Arendt T., Bruckner M.K., Lange M., and Bigl V. Changes in acetylcholinesterase and butyrylcholinesterase in Alzheimer's disease resemble embryonic development - a study of molecular forms. Neurochem. Int. 21 (1992) 381-396
50. Farlow M., Gracon S.I., Hershey L.A., Lewis K.W., Sadowsky C.H., and Dolan-Ureno J. A controlled trial of Tacrine in Alzheimer's disease. JAMA 268 (1992) 2523-2529
51. Bai D.L., Tang X.C., and He X.C. Huperzine A, a potential therapeutic agent for treatment of Alzheimer's disease. Curr. Med. Chem. 7 (2000) 355-374
52. Wang R., Zhang H.Y., and Tang X.C. Huperzine A attenuates cognitive dysfunction and neuronal degeneration caused by β-amyloid protein-(1-40) in rat. Eur. J. Pharmacol. 421 (2001) 149-156